The Conquer Cancer Young Investigator Award in Mantle Cell Lymphoma provides mentored research funding to promising physician-investigators transitioning from oncology training or fellowship to an academic faculty appointment.
The award supports clinical, translational, and clinically relevant preclinical research focused on mantle cell lymphoma. Eligible projects may also include epidemiological, behavioural, quality-of-care, outcomes, and health-services research. Applications are accepted from eligible investigators working in the United States and internationally.
Eligibility Criteria:
- Applicants must be physicians holding an MD, DO, or international equivalent.
- Applicants must generally be within 10 years of receiving their medical degree. Exceptions may be considered for some international medical graduates and fellows in prolonged specialist training pathways.
- Applicants must have a mentor from the sponsoring institution.
- Applicants must commit at least 60% of their overall professional time to research during the award period.
- Applicants may apply to both the general YIA and YIA special competitions but may accept only the first formal award offered.
- First-year faculty members may apply to either the Young Investigator Award or the Career Development Award during the same cycle, but not both.
- Previous or current recipients of the Conquer Cancer–AACR Young Investigator Award for Translational Cancer Research are not eligible.
Funding Details:
- The total award amount is USD 50,000 for one year.
- Funding is paid to the sponsoring institution in two instalments of USD 25,000.
- One award is expected to be funded through the 2027 competition.
Deadline:
- Applications opened: July 1, 2026.
- Full application deadline: March 11, 2027, at 11:59 p.m. Eastern Time.
- Technical assistance is available only until 5:00 p.m. Eastern Time on the deadline date.
- Award notification: April 2027.
- Award term: July 1, 2027–June 30, 2028.
Further Information:
- Projects must focus on mantle cell lymphoma and may include clinical, translational, preclinical, epidemiological, behavioural, outcomes, quality-of-care, or health-services research.
- Clinical proposals must be developed with a patient advocate; patient-advocate involvement is strongly encouraged for preclinical projects.
- Applications require a four-page research strategy, one-page biostatistical plan, patient-impact section, budget, timeline, biosketch, mentorship plan, and institutional support letter.
- All materials must be prepared in English and submitted through the ASCO and Conquer Cancer Application Portal; email, fax, and paper applications are not accepted.
- Applicants with eligibility questions may contact grants@conquer.org, and projects involving a company-supplied drug must include documentation confirming drug availability.